Jeff Yass’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Other funds holding PRQR
6CM
KCM
LCM
Jeff Yass's PRQR Position: Q3 2026 in Review
Jeff Yass opened a new position in ProQR Therapeutics (PRQR) in Q3 2026: 17,667 shares worth $29.3K. The stake represents ﹤0.01% of the portfolio and ranks #13045 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PRQR as recently as Q1 2026.
Jeff Yass first reported a position in PRQR in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.07M in Q3 2021. 73 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.
- Jeff Yass held 17,667 shares of ProQR Therapeutics worth $29.3K as of Q3 2026.
- ProQR Therapeutics was a new Jeff Yass position in Q3 2026.
- ProQR Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13045 holding.
- Jeff Yass first reported a position in ProQR Therapeutics in Q4 2017 and has held it in 20 quarters since.
- Jeff Yass's ProQR Therapeutics position peaked at $1.07M in Q3 2021.
- 73 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.